Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy
نویسندگان
چکیده
منابع مشابه
The Pharmacogenomics of Anti-Hypertensive Therapy
Hypertension is a major public health problem, but measures to reduce blood pressure and thus cardiovascular risk are complicated by the high prevalence of treatment resistance, despite the availability of multiple drugs. Drug side-effects contribute considerably to suboptimal blood pressure control. Clinicians must often rely on empirical methods to match patients with effective drug treatment...
متن کاملNovel agents for anti-platelet therapy
Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases. The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio-cerebrovascular diseases. Glycoprotein IIb/IIIa antagonists (e.g., abciximab, eptifibatide and tirofiban) have demonstrated good clinical benefits an...
متن کاملAnti-platelet therapy: ADP receptor antagonists
The P2Y(12) receptor on platelets with which ADP interacts has an important role in promoting platelet function and thereby platelet involvement in both haemostasis and thrombosis. Agents that act as antagonists at this receptor are thus likely to provide effective antithrombotic therapy, provided that there are no adverse effects on haemostasis. Here we describe the ADP receptor antagonists th...
متن کاملAnti-platelet therapy for Acute Coronary Syndrome
The term ‘Acute Coronary Syndrome’ (ACS) refers to a range of acute myocardial ischaemic states which include unstable angina, non ST segment elevation myocardial infarction (NSTEMI) and ST segment elevation myocardial infarction (STEMI). Despite significant advances in the diagnosis and management, ACS remains a significant global problem with very high mortality and morbidity. The pathogeneti...
متن کاملAnti-coagulation therapy following coronary endarterectomy in patient with coronary artery bypass graft
Background: Since there is a lack of research on postoperative anticoagulation protocol in patients undergoing coronary artery bypass graft (CABG) / coronary endarterectomy (CE), we recommend a new protocol for anticoagulation in these patients. Methods: In this double-blind randomized clinical trial study, 52 patients undergoing CABG / CE entered the study and were divided into two groups. In...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Cardiology Reports
سال: 2013
ISSN: 1523-3782,1534-3170
DOI: 10.1007/s11886-013-0381-3